ID
15375
Description
Study documentation part: Concomitant medication Study short name: DIMAT MS Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. Principal Investigator PD Dr. Luisa Klotz, University Hospital Münster EudraCT - No.: 2014-003481-25. Clinical Trial No.: NCT02461069. Please list below concomitant medications which are taken within a period from 30 days prior to Screening until the end of the study participation. Please list below signi cant non-drug therapies which are performed over the course of study participation.
Keywords
Versions (2)
- 5/28/16 5/28/16 -
- 5/28/16 5/28/16 -
Uploaded on
May 28, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Concomitant medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis DRKS00008037 NCT02461069
Concomitant medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis NCT02461069
Description
Signature
Similar models
Concomitant medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis NCT02461069
C0599938 (UMLS CUI [2])
C0011008 (UMLS CUI [1,2])